A recent study showed that medulloblastomas can be subdivided into two prognostically different subgroups according to the G-protein alpha subunit Gsα (GNAS) levels: SHH-mutated GNAS-high tumors have a markedly better overall survival compared to SHH-mutated, GNAS-low tumors [183]. Here, SHH is linked to medulloblastoma.